BRIEF-Cytokinetics starts phase 3 clinical trial of omecamtiv mecarbil
December 01, 2016 at 07:51 AM EST
* Cytokinetics announces start of galactic-hf, a phase 3 clinical trial of omecamtiv mecarbil
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|